Research menu
Jump to menu

Publications:  Prof Andrew Prendergast

Bourke CD, Prendergast AJ(2020). The Anti-inflammatory Effects of Cotrimoxazole Prophylaxis for People Living With Human Immunodeficiency Virus in Sub-Saharan Africa. The Journal of infectious diseases vol. 222, (3) 347-350.
Ntozini R, Chandna J, Evans C, Chasekwa B, Majo FD, Kandawasvika G, Tavengwa NV, Mutasa B et al.(2020). Early child development in children who are HIV-exposed uninfected compared to children who are HIV-unexposed: observational sub-study of a cluster-randomized trial in rural Zimbabwe. Journal of the International AIDS Society vol. 23, (5)
Church JA, Chasekwa B, Rukobo S, Govha M, Lee B, Carmolli MP, Ntozini R, Mutasa K et al.(2020). Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants. Vaccine vol. 38, (13) 2870-2878.
Gough E, Bourke C, Berejena C, Shonhai A, Bwakura-Dangarembizi M, Prendergast A, Manges AR(2020). Strain-level analysis of gut-resident pro-inflammatory viridans group Streptococci suppressed by long-term cotrimoxazole prophylaxis among HIV-positive children in Zimbabwe. Gut Microbes Article KGMI-20190194R1,
Gough EK, Moulton LH, Mutasa K, Ntozini R, Stoltzfus RJ, Majo FD, Smith LE, Panic G et al.(2020). Effects of improved water, sanitation, and hygiene and improved complementary feeding on environmental enteric dysfunction in children in rural Zimbabwe: A cluster-randomized controlled trial. PLoS Neglected Tropical Diseases vol. 14, (2)
Evans C, Chasekwa B, Ntozini R, Majo FD, Mutasa K, Tavengwa N, Mutasa B, Mbuya MNN et al.(2020). Mortality, HIV transmission and growth in children exposed to HIV in rural Zimbabwe. Clinical Infectious Diseases
Bourke C(2019). Determinants of urogenital schistosomiasis among pregnant women and its impact on pregnancy outcomes, neonatal deaths and child growth. Journal of Infectious Diseases
Church J, Prendergast A(2019). Enteropathogens were not associated with rotavirus vaccine immunogenicity in a cluster-randomized trial of improved water, sanitation and hygiene in rural Zimbabwe. Pediatric Infectious Disease Journal
Wedderburn CJ, Evans C, Yeung S, Gibb DM, Donald KA, Prendergast AJ(2019). Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework. Current HIV/AIDS Reports vol. 16, (6) 501-513.
Pickering AJ, Arnold BF, Prendergast AJ, Null C, Winch PJ, Njenga SM, Rahman M, Ntozini R et al.(2019). Moving towards transformational WASH – Authors' reply. The Lancet Global Health vol. 7, (11) e1494-e1495.
Kelly P, Bell L, Amadi B, Bwakura-Dangarembizi M, Vanbuskirk K, Chandwe K, Chipunza M, Ngosa D et al.(2019). TAME trial: A multi-arm phase II randomised trial of four novel interventions for malnutrition enteropathy in Zambia and Zimbabwe - A study protocol. BMJ Open vol. 9, (11)
Prendergast AJ, Walson JL(2019). Seeking interventions to reduce post-discharge mortality among children in sub-Saharan Africa. The Lancet Global Health vol. 7, (10) e1306-e1307.
Cumming O, Arnold BF, Ban R, Clasen T, Esteves Mills J, Freeman MC, Gordon B, Guiteras R et al.(2019). The implications of three major new trials for the effect of water, sanitation and hygiene on childhood diarrhea and stunting: A consensus statement. BMC Medicine vol. 17, (1)
Prendergast AJ, Gharpure R, Mor S, Viney M, Dube K, Lello J, Berger C, Siwila J et al.(2019). Putting the “A” into WaSH: a call for integrated management of water, animals, sanitation, and hygiene. Lancet Planetary Health vol. 3, (8) e336-e337.
Pickering AJ, Null C, Winch PJ, Mangwadu G, Arnold BF, Prendergast AJ, Njenga SM, Rahman M et al.(2019). The WASH Benefits and SHINE trials: interpretation of WASH intervention effects on linear growth and diarrhoea. The Lancet Global Health vol. 7, (8) e1139-e1146.
Bourke C, Jones KDJ, Prendergast AJ(2019). Current understanding of innate immune cell dysfunction in childhood undernutrition. Frontiers in Immunology
Prendergast AJ, Berejena C, Pimundu G, Shonhai A, Bwakura-Dangarembizi M, Musiime V, Szubert AJ, Cook AD et al.(2019). Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe. AIDS vol. 33, (9) 1485-1490.
Humphrey J, Pickering A, Null C, Winch P, Mangwadu G, Arnold B, Prendergast A, Njenga S et al.(2019). The WASH Benefits and SHINE Trials. Interpretation of Findings on Linear Growth and Diarrhoea and Implications for Policy: Perspective of the Investigative Teams (P10-136-19). Curr Dev Nutr vol. 3, (Suppl 1)
Rogawski McQuade ET, Platts-Mills JA, Gratz J, Zhang J, Moulton LH, Mutasa K, Majo FD, Tavengwa N et al.(2019). Impact of water quality, sanitation, handwashing, and nutritional interventions on enteric infections in rural Zimbabwe: the Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial. Journal of Infectious Diseases
BOURKE CD, PRENDERGAST A, DEAYTON J, PARDIEU C, Naheed C(2019). Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation. Science Translational Medicine vol. 11,
Sturgeon JP, Bourke CD, PRENDERGAST AJ(2019). Children With Noncritical Infections Have Increased Intestinal Permeability, Endotoxemia and Altered Innate Immune Responses. The Pediatric Infectious Disease Journal1-1.
Prendergast AJ, Goga AE, Waitt C, Gessain A, Taylor GP, Rollins N, Abrams EJ, Lyall EH et al.(2019). Transmission of CMV, HTLV-1, and HIV through breastmilk. The Lancet Child and Adolescent Health vol. 3, (4) 264-273.
Mbuya MNN, Matare CR, Tavengwa NV, Chasekwa B, Ntozini R, Majo FD, Chigumira A, Chasokela CMZ et al.(2019). Early Initiation and Exclusivity of Breastfeeding in Rural Zimbabwe: Impact of a Breastfeeding Intervention Delivered by Village Health Workers. Current Developments in Nutrition vol. 3, (4)
Gladstone MJ, Chandna J, Kandawasvika G, Ntozini R, Majo FD, Tavengwa NV, Mbuya MNN, Mangwadu GT et al.(2019). Independent and combined effects of improved water, sanitation, and hygiene (Wash) and improved complementary feeding on early neurodevelopment among children born to hiv-negative mothers in rural zimbabwe: Sub study of a cluster-randomized trial. PLoS Medicine vol. 16, (3)
CHURCH JA, PRENDERGAST A(2019). The impact of improved water, sanitation and hygiene on oral rotavirus vaccine immunogenicity in Zimbabwean infants: sub-study of a cluster-randomized trial. Clinical Infectious Diseases
BOURKE CD, PRENDERGAST A, ROBERTSON R(2019). Health Outcomes, Pathogenesis and Epidemiology of Severe Acute Malnutrition (HOPE-SAM): rationale and methods of a longitudinal observational study. BMJ Open
Prendergast AJ, Chasekwa B, Evans C, Mutasa K, Mbuya MNN, Stoltzfus RJ, Smith LE, Majo FD et al.(2019). Independent and combined effects of improved water, sanitation, and hygiene, and improved complementary feeding, on stunting and anaemia among HIV-exposed children in rural Zimbabwe: a cluster-randomised controlled trial. The Lancet Child and Adolescent Health vol. 3, (2) 77-90.
Robertson RC, Manges AR, Finlay BB, Prendergast AJ(2019). The Human Microbiome and Child Growth – First 1000 Days and Beyond. Trends in Microbiology vol. 27, (2) 131-147.
CHURCH JA, PRENDERGAST A, Parker EP, Kirkpatrick BD, Grassly NC(2019). Interventions to improve oral vaccine performance in developing countries: a systematic review and meta-analysis. The Lancet Infectious Diseases vol. 19, (2) 203-214.
Spyridou C, Ragab H, Murphy RA, Riddell A, Wilks M, Millar MR, Prendergast AJ(2019). Two Cases of BCG Osteomyelitis Diagnosed Through Polymerase Chain Reaction/Electrospray Ionization-Mass Spectrometry Technology. Clinical Infectious Diseases vol. 68, (2)
Humphrey JH, Mbuya MNN, Ntozini R, Moulton LH, Stoltzfus RJ, Tavengwa NV, Mutasa K, Majo F et al.(2019). Independent and combined effects of improved water, sanitation, and hygiene, and improved complementary feeding, on child stunting and anaemia in rural Zimbabwe: a cluster-randomised trial. The Lancet Global Health vol. 7, (1) e132-e147.
Fitzgerald FC, Lhomme E, Harris K, Kenny J, Doyle R, Kityo C, Shaw LP, Abongomera G et al.(2019). Microbial translocation does not drive immune activation in ugandan children infected with HIV. Journal of Infectious Diseases vol. 219, (1) 89-100.
CHURCH JA, Rukobo S, Govha M, Carmolli MP, Diehl SA, Chasekwa B, Ntozini R, Mutasa K et al.(2018). Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants. Transactions of The Royal Society of Tropical Medicine and Hygiene
Church JA, Parker EP, Kosek MN, Kang G, Grassly NC, Kelly P, Prendergast AJ(2018). Exploring the relationship between environmental enteric dysfunction and oral vaccine responses. Future Microbiol
Freer JB, Bourke CD, Durhuus GH, Kjetland EF, Prendergast AJ(2018). Schistosomiasis in the first 1000 days. The Lancet Infectious Diseases vol. 18, (6) e193-e203.
Mallewa J, Szubert AJ, Mugyenyi P, Chidziva E, Thomason MJ, Chepkorir P, Abongomera G, Baleeta K et al.(2018). Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial. The Lancet HIV vol. 5, (5) e231-e240.
Post FA, Szubert AJ, Prendergast AJ, Johnston V, Lyall H, Fitzgerald F, Musiime V, Musoro G et al.(2018). Causes and Timing of Mortality and Morbidity among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial. Clinical Infectious Diseases vol. 66, S132-S139.
Siika A, McCabe L, Bwakura-Dangarembizi M, Kityo C, Mallewa J, Berkley J, Maitland K, Griffiths A et al.(2018). Late Presentation with HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial. Clinical Infectious Diseases vol. 66, S140-S146.
Karampatsas K, Osborne L, Seah ML, Tong CYW, Prendergast AJ(2018). Clinical characteristics and complications of rotavirus gastroenteritis in children in east London: A retrospective case-control study. PLoS ONE vol. 13, (3)
Harper KM, Mutasa M, Prendergast AJ, Humphrey J, Manges AR(2018). Environmental enteric dysfunction pathways and child stunting: A systematic review. PLoS Negl Trop Dis vol. 12, (1) e0006205-e0006205.
Prendergast AJ, Penazzato M(2018). Timing of antiretroviral therapy in children with advanced HIV. The Lancet HIV vol. 5, (1) e2-e3.
Parker EP, Ramani S, Lopman BA, Church JA, Iturriza-Gómara M, Prendergast AJ, Grassly NC(2017). Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol vol. 13, 97-118.
Humphrey JH, Prendergast AJ(2017). Population-level linear growth faltering in low-income and middle-income countries. The Lancet Global Health vol. 5, (12) e1168-e1169.
Szubert AJ, Prendergast AJ, Spyer MJ, Musiime V, Musoke P, Bwakura-Dangarembizi M, Nahirya-Ntege P, Thomason MJ et al.(2017). Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial. PLoS Med vol. 14, (11) Article 1002432, e1002432-e1002432.
Leitman EM, Thobakgale CF, Adland E, Ansari MA, Raghwani J, Prendergast AJ, Tudor-Williams G, Kiepiela P et al.(2017). Role of HIV-specific CD8+ T cells in pediatric HIV cure strategies after widespread early viral escape. Journal of Experimental Medicine vol. 214, (11) 3239-3261.
Omoni AO, Ntozini R, Evans C, Prendergast AJ, Moulton LH, Christian PS, Humphrey JH(2017). Child Growth According to Maternal and Child HIV Status in Zimbabwe. Pediatr Infect Dis J vol. 36, (9) 869-876.
Smith LE, Mbuya MNN, Prendergast AJ, Turner PC, Ruboko S, Humphrey JH, Nelson RJ, Chigumira A et al.(2017). Determinants of recent aflatoxin exposure among pregnant women in rural Zimbabwe. Molecular Nutrition and Food Research vol. 61, (9)
CHURCH JA, Prendergast A(2017). Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants. Human Vaccines and Immunotherapeutics
Amadi B, Besa E, Zyambo K, Kaonga P, Louis-Auguste J, Chandwe K, Tarr PI, Denno DM et al.(2017). Impaired Barrier Function and Autoantibody Generation in Malnutrition Enteropathy in Zambia. EBioMedicine vol. 22, 191-199.
Hakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C, Walker S, Pett SL et al.(2017). Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa. N Engl J Med vol. 377, (3) 233-245.
Dodd PJ, Prendergast AJ, Beecroft C, Kampmann B, Seddon JA(2017). The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis. Thorax vol. 72, (6) 559-575.
Evans C, Prendergast AJ (2017). Co-trimoxazole for HIV-exposed uninfected infants. vol. 5, is. 5, pp. e468-e469.
Piper JD, Chandna J, Allen E, Linkman K, Cumming O, Prendergast AJ, Gladstone MJ(2017). Water, sanitation and hygiene (WASH) interventions: Effects on child development in low- and middle-income countries. Cochrane Database of Systematic Reviews vol. 2017, (3)
Smith LE, Prendergast AJ, Turner PC, Humphrey JH, Stoltzfus RJ(2017). Aflatoxin Exposure During Pregnancy, Maternal Anemia, and Adverse Birth Outcomes. Am J Trop Med Hyg vol. 96, (4) 770-776.
Evans C, Chasekwa B, Rukobo S, Govha M, Mutasa K, Ntozini R, Humphrey JH, Prendergast AJ(2017). Cytomegalovirus acquisition and inflammation in human immunodeficiency virus-exposed uninfected Zimbabwean infants. Journal of Infectious Diseases vol. 215, (5) 698-702.
Prendergast AJ, Chasekwa B, Rukobo S, Govha M, Mutasa K, Ntozini R, Humphrey JH(2017). Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants. Journal of Infectious Diseases vol. 216, (6) 651-661.
Barlow-Mosha L, Musiime V, Davies MA, Prendergast AJ, Musoke P, Siberry G, Penazzato M(2017). Universal antiretroviral therapy for HIV-infected children: A review of the benefits and risks to consider during implementation: A. Journal of the International AIDS Society vol. 20, (1)
Gough EK, Moodie EEM, Prendergast AJ, Ntozini R, Moulton LH, Humphrey JH, Manges AR(2016). Linear growth trajectories in Zimbabwean infants1,2. American Journal of Clinical Nutrition vol. 104, (6) 1616-1627.
Prendergast AJ, Bwakura-Dangarembizi M, Mugyenyi P, Lutaakome J, Kekitiinwa A, Thomason MJ, Gibb DM, Walker AS(2016). Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis. AIDS vol. 30, (18) 2823-2829.
Muenchhoff M, Adland E, Karimanzira O, Crowther C, Pace M, Csala A, Leitman E, Moonsamy A et al.(2016). Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection. Science Translational Medicine vol. 8, (358)
Evans C, Chasekwa B, Ntozini R, Humphrey JH, Prendergast AJ(2016). Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the preantiretroviral therapy era. AIDS vol. 30, (15) 2323-2328.
Hakim J, Musiime V, Szubert AJ, Siika A, Mallewa J, Agutu C, Pett SL, Bwakura-Dangarembizi M et al. (2016). Enhanced infection prophylaxis reduces mortality in severely immunosuppressed HIV-infected adults and older children initiating antiretroviral therapy in Kenya, Malawi, Uganda and Zimbabwe: the REALITY trial. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. vol. 19,
Evans C, Humphrey JH, Ntozini R, Prendergast AJ(2016). HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era. Front Immunol vol. 7, Article 190,
Evans C, Jones CE, Prendergast AJ(2016). HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. The Lancet Infectious Diseases vol. 16, (6) e92-e107.
Prendergast AJ, Kelly P(2016). Interactions between intestinal pathogens, enteropathy and malnutrition in developing countries. Curr Opin Infect Dis vol. 29, (3) 229-236.
BOURKE CD, Berkley JA, Prendergast AJ(2016). Immune Dysfunction as a Cause and Consequence of Malnutrition. Trends in Immunology vol. 37, (6) Article TREIMM_1280, 386-398.
Prendergast AJ, Szubert AJ, Berejena C, Pimundu G, Pala P, Shonhai A, Musiime V, Bwakura-Dangarembizi M et al.(2016). Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy. Journal of Infectious Diseases
Musiime V, Prendergast AJ(2016). Can abacavir be used safely in children without HLA testing?. The Lancet HIV vol. 3, (2) e58-e59.
Gough EK, Stephens DA, Moodie EEM, Prendergast AJ, Stoltzfus RJ, Humphrey JH, Manges AR(2016). Erratum: Linear growth faltering in infants is associated with Acidaminococcus sp. and community-level changes in the gut microbiota [Microbiome, 3, (2015): 24]. DOI 10.1186/s40168-016-0149-2. Microbiome vol. 4,
Crook AM, Turkova A, Musiime V, Bwakura-Dangarembizi M, Bakeera-Kitaka S, Nahirya-Ntege P, Thomason M, Mugyenyi P et al.(2016). Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy. BMC Medicine vol. 14, (1)
Gough EK, Prendergast AJ, Mutasa KE, Stoltzfus RJ, Manges AR(2015). Assessing the intestinal microbiota in the SHINE Trial. Clinical Infectious Diseases vol. 61, S738-S744.
Prendergast AJ, Humphrey JH, Mutasa K, Majo FD, Rukobo S, Govha M, Mbuya MNN, Moulton LH et al.(2015). Assessment of environmental enteric dysfunction in the SHINE Trial: Methods and challenges. Clinical Infectious Diseases vol. 61, S726-S732.
Smith LE, Prendergast AJ, Turner PC, Mbuya MNN, Mutasa K, Kembo G, Stoltzfus RJ(2015). The potential role of mycotoxins as a contributor to stunting in the SHINE Trial. Clinical Infectious Diseases vol. 61, S733-S737.
Humphrey JH, Jones AD, Manges A, Mangwadu G, Maluccio JA, Mbuya MNN, Moulton LH, Ntozini R et al.(2015). The sanitation hygiene infant nutrition efficacy (SHINE) Trial: Rationale, design, and methods. Clinical Infectious Diseases vol. 61, S685-S702.
Karampatsas K, Spyridou C, Morrison IR, Tong CYW, Prendergast AJ(2015). Rotavirus-associated mild encephalopathy with a reversible splenial lesion (MERS)-case report and review of the literature. BMC Infectious Diseases vol. 15, (1)
Venkataraman A, Yusuff M, Liebeschuetz S, Riddell A, Prendergast AJ(2015). Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions. Vaccine vol. 33, (41) 5470-5474.
Musoke P, Szubert AJ, Musiime V, Nathoo K, Nahirya-Ntege P, Mutasa K, Williams DE, Prendergast AJ et al.(2015). Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years. AIDS vol. 29, (13) 1623-1632.
Mupfudze TG, Stoltzfus RJ, Rukobo S, Moulton LH, Humphrey JH, Prendergast AJ(2015). Plasma concentrations of hepcidin in anemic zimbabwean infants. PLoS ONE vol. 10, (8)
Thobakgale CF, Prendergast A, Crawford H, Mkhwanazi N, Ramduth D, Reddy S, Molina C, Mncube Z et al.(2015). Correction for Thobakgale et al., Impact of HLA in Mother and Child on Disease Progression of Pediatric Human Immunodeficiency Virus Type 1 Infection. J Virol vol. 89, (15)
Gulati A, Gale J, Prendergast A, Cerio R, Dhoat S (2015). Sniffing out a diagnostic dilemma: TB or not TB?. BRITISH JOURNAL OF DERMATOLOGY. vol. 173, 168-168.
Prendergast AJ(2015). Malnutrition and vaccination in developing countries. Philosophical Transactions of the Royal Society B: Biological Sciences vol. 370, (1671)
Chisenga CC, Filteau S, Siame J, Chisenga M, Prendergast AJ, Kelly P(2015). T-cell subsets predict mortality in malnourished Zambian adults initiating antiretroviral therapy. PLoS ONE vol. 10, (6)
Szubert AJ, Musiime V, Bwakura-Dangarembizi M, Nahirya-Ntege P, Kekitiinwa A, Gibb DM, Nathoo K, Prendergast AJ et al.(2015). Pubertal development in HIV-infected African children on first-line antiretroviral therapy. AIDS vol. 29, (5) 609-618.
Jones AD, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya MNN, Stoltzfus RJ, Humphrey JH et al.(2015). Acute illness is associated with suppression of the growth hormone axis in Zimbabwean infants. Am J Trop Med Hyg vol. 92, (2) 463-470.
Bwakura-Dangarembizi M, Musiime V, Szubert AJ, Prendergast AJ, Gomo ZA, Thomason MJ, Musarurwa C, Mugyenyi P et al.(2015). Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy. Pediatr Infect Dis J vol. 34, (2) e23-e31.
Adland E, Paioni P, Thobakgale C, Laker L, Mori L, Muenchhoff M, Csala A, Clapson M et al.(2015). Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection. PLoS Pathogens vol. 11, (6)
Prendergast AJ, Essajee S, Penazzato M(2015). HIV and the millennium development goals. Archives of Disease in Childhood vol. 100, S48-S52.
Gough EK, Stephens DA, Moodie EEM, Prendergast AJ, Stoltzfus RJ, Humphrey JH, Manges AR(2015). Linear growth faltering in infants is associated with Acidaminococcus sp. and community-level changes in the gut microbiota. Microbiome vol. 3,
Mori M, Adland E, Paioni P, Swordy A, Mori L, Laker L, Muenchhoff M, Matthews PC et al.(2015). Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection. PloS one vol. 10, (7)
Prendergast AJ, Humphrey JH(2015). Stunting Persists despite Optimal Feeding: Are Toilets Part of the Solution?. Nestle Nutrition Institute Workshop Series vol. 81, 99-110.
Church JA, Fitzgerald F, Walker AS, Gibb DM, Prendergast AJ(2015). The expanding role of co-trimoxazole in developing countries. The Lancet Infectious Diseases vol. 15, (3) 327-339.
Karampatsas K, Patel H, Basheer SN, Prendergast AJ(2014). Chronic meningitis with intracranial hypertension and bilateral neuroretinitis following Mycoplasma pneumoniae infection. BMJ Case Reports vol. 2014,
Gumbo H, Chasekwa B, Church JA, Ntozini R, Mutasa K, Humphrey JH, Prendergast AJ(2014). Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants. PLoS ONE vol. 9, (12)
Prendergast AJ, Humphrey JH(2014). The stunting syndrome in developing countries. Paediatrics and International Child Health vol. 34, (4) 250-265.
Penazzato M, Revill P, Prendergast AJ, Collins IJ, Walker S, Elyanu PJ, Sculpher M, Gibb DM(2014). Early infant diagnosis of HIV infection in low-income and middle-income countries: does one size fit all?. Lancet Infect Dis vol. 14, (7) 650-655.
Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams E(2014). Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age. Cochrane Database Syst Rev (5)
Gough EK, Moodie EEM, Prendergast AJ, Johnson SMA, Humphrey JH, Stoltzfus RJ, Walker AS, Trehan I et al.(2014). The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials. BMJ-BRITISH MEDICAL JOURNAL vol. 348, Article ARTN g2267,
Palha De Sousa CA, Brigham T, Chasekwa B, Mbuya MNN, Tielsch JM, Humphrey JH, Prendergast AJ(2014). Dosing of praziquantel by height in sub-Saharan African adults. Am J Trop Med Hyg vol. 90, (4) 634-637.
Prendergast A, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya M, Jones A, Moulton L et al. (2014). Stunting is characterized by chronic inflammation in Zimbabwean infants. FASEB JOURNAL. vol. 28,
Mupfudze T, Stoltzfus R, Rukobo S, Moulton L, Humprey J, Prendergast A(2014). The role of hepcidin in the pathogenesis of anemia in Zimbabwean infants. FASEB JOURNAL vol. 28, (1)
Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams EJ(2014). Optimization of antiretroviral therapy in HIV-infected children under 3 years of age: a systematic review. AIDS vol. 28 Suppl 2, S137-S146.
Mupfudze TG, Stoltzfus RJ, Rukobo S, Moulton LH, Humphrey JH, Prendergast AJ, Team SHINEP(2014). Hepcidin decreases over the first year of life in healthy African infants. BRITISH JOURNAL OF HAEMATOLOGY vol. 164, (1) 150-153.
Muenchhoff M, Prendergast AJ, Goulder PJR(2014). Immunity to HIV in Early Life. Front Immunol vol. 5,
Lindenmayer GW, Stoltzfus RJ, Prendergast AJ(2014). Interactions between Zinc Deficiency and Environmental Enteropathy in Developing Countries. ADVANCES IN NUTRITION vol. 5, (1) 1-6.
Prendergast AJ, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya MNN, Jones A, Moulton LH et al.(2014). Stunting is characterized by chronic inflammation in Zimbabwean infants. PLoS One vol. 9, (2)
Ngure FM, Humphrey JH, Mbuya MNN, Majo F, Mutasa K, Govha M, Mazarura E, Chasekwa B et al.(2013). Formative research on hygiene behaviors and geophagy among infants and young children and implications of exposure to fecal bacteria. Am J Trop Med Hyg vol. 89, (4) 709-716.
Picat M-Q, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, Ntege PN, Gibb DM et al.(2013). Predicting Patterns of Long-Term CD4 Reconstitution in HIV-Infected Children Starting Antiretroviral Therapy in Sub-Saharan Africa: A Cohort-Based Modelling Study. PLOS MEDICINE vol. 10, (10) Article ARTN e1001542,
Musiime V, Cook A, Bakeera-Kitaka S, Vhembo T, Lutakome J, Keishanyu R, Prendergast AJ, Lubwama S et al.(2013). Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and Zimbabwe. Pediatr Infect Dis J vol. 32, (8) 856-862.
Jones AD, Prendergast AJ, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mduduzi MNN, Stoltzfus RJ et al. (2013). Chronic immune activation in Zimbabwean infants mediates the influence of clinical morbidity on child growth. FASEB JOURNAL. vol. 27,
Prendergast AJ(2013). Complications of long-term antiretroviral therapy in HIV-infected children. Arch Dis Child vol. 98, (4) 245-246.
Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, Nahirya- Ntege P, Keishanyu, R, Nathoo K, Spyer MJ, Kekitiinwa A et al.(2013). A Randomized Trial of Prolonged Cotrimoxazole in HIV-Infected Children in Africa. NEJM vol. 370, 41-53.
Walker AS, Prendergast AJ, Mugyenyi P, Munderi P, Hakim J, Kekitiinwa A, Katabira E, Gilks CF et al.(2012). Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. Clin Infect Dis vol. 55, (12) 1707-1718.
Mutasa K, Ntozini R, Prendergast A, Iliff P, Rukobo S, Moulton LH, Ward BJ, Humphrey JH et al.(2012). Impact of six-week viral load on mortality in HIV-infected Zimbabwean infants. Pediatr Infect Dis J vol. 31, (9) 948-950.
Prendergast AJ, Klenerman P, Goulder PJR(2012). The impact of differential antiviral immunity in children and adults. Nat Rev Immunol vol. 12, (9) 636-648.
Smith LE, Stoltzfus RJ, Prendergast A(2012). Food chain mycotoxin exposure, gut health, and impaired growth: a conceptual framework. Adv Nutr vol. 3, (4) 526-531.
Prendergast A, Kelly P(2012). Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg vol. 86, (5) 756-763.
Prendergast A, O'Callaghan M, Menson E, Hamadache D, Walters S, Klein N, Goulder P(2012). Factors influencing T cell activation and programmed death 1 expression in HIV-infected children. AIDS Res Hum Retroviruses vol. 28, (5) 465-468.
Penazzato M, Prendergast A, Tierney J, Cotton M, Gibb D(2012). Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age. COCHRANE DATABASE OF SYSTEMATIC REVIEWS (7) Article ARTN CD004772,
Prendergast AJ, Penazzato M, Cotton M, Musoke P, Mulenga V, Abrams EJ, Gibb DM(2012). Treatment of young children with HIV infection: using evidence to inform policymakers. PLoS Med vol. 9, (7)
Thobakgale CF, Streeck H, Mkhwanazi N, Mncube Z, Maphumulo L, Chonco F, Prendergast A, Tudor-Williams G et al.(2011). Short Communication: CD8(+) T Cell Polyfunctionality Profiles in Progressive and Nonprogressive Pediatric HIV Type 1 Infection. AIDS RES HUM RETROV vol. 27, (9) 1005-1012.
Prendergast A, Goodliffe H, Clapson M, Cross R, Tudor-Williams G, Riddell A, Daniels J, Williams A et al.(2011). Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection. AIDS vol. 25, (10) 1329-1331.
Prendergast A, Bwakura-Dangarembizi MF, Cook AD, Bakeera-Kitaka S, Natukunda E, Nahirya Ntege P, Nathoo KJ, Karungi C et al.(2011). Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy. AIDS vol. 25, (7) 951-956.
Prendergast A, Walker AS, Mulenga V, Chintu C, Gibb DM(2011). Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis. Clin Infect Dis vol. 52, (7) 953-956.
Goulder PJR, Prendergast AJ(2011). Approaches towards avoiding lifelong antiretroviral therapy in paediatric HIV infection. Adv Exp Med Biol vol. 719, 25-37.
Prendergast A, Prado JG, Kang Y-H, Chen F, Riddell LA, Luzzi G, Goulder P, Klenerman P(2010). HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS vol. 24, (4) 491-502.
Prado JG, Prendergast A, Thobakgale C, Molina C, Tudor-Williams G, Ndung'u T, Walker BD, Goulder P(2010). Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate. J Virol vol. 84, (1) 492-502.
Matthews P, Prendergast A, Kawashima Y, Pfafferott K, Frater J, Heckerman D, Takiguchi M, Goulder P(2009). INTER-CONTINENTAL PATTERNS OF HIV-1 CONTROL: HLA AND THE QUEST FOR A T CELL VACCINE. J INFECTION vol. 59, (6) S430-S431.
Thobakgale CF, Prendergast A, Crawford H, Mkhwanazi N, Ramduth D, Reddy S, Molina C, Mncube Z et al.(2009). Impact of HLA in Mother and Child on Disease Progression of Pediatric Human Immunodeficiency Virus Type 1 Infection. J VIROL vol. 83, (19) 10234-10244.
Matthews PC, Leslie AJ, Katzourakis A, Crawford H, Payne R, Prendergast A, Power K, Kelleher AD et al.(2009). HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering. J Virol vol. 83, (9) 4605-4615.
Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, Gatanaga H, Fujiwara M et al.(2009). Adaptation of HIV-1 to human leukocyte antigen class I. NATURE vol. 458, (7238) 641-U108.
English S, Katzourakis A, Flanagan P, Duda A, Francis J, Matthews P, Prendergast A, Goulder P et al.(2009). Contemporaneous transmission of genetically distinct HIV variants from a single donor to two recipients. RETROVIROLOGY vol. 6, Article P107,
Prendergast A, Prado JG, Kang Y, Chen F, Riddell LA, Luzzi G, Goulder P, Klenerman P(2009). HIV-1 infection is characterized by early loss of CD161+Th17 cells and gradual decline in regulatory T cells. RETROVIROLOGY vol. 6, Article O19,
Prado JG, Prendergast A, Thobakgale C, Juarez C, Tudor-Williams A, Ndung'u T, Walker BD, Goulder P(2009). Non-progressive paediatric HIV infection is associated with virus attenuation and increase in CD8+specific T cell responses over time. RETROVIROLOGY vol. 6, Article P105,
Prendergast A, Klenerman P, Goulder P (2008). Expression of Inducible Costimulator (ICOS) on T Cells is Associated with HIV Disease Progression. AIDS RESEARCH AND HUMAN RETROVIRUSES. vol. 24, 130-130.
Matthews PC, Prendergast A, Leslie A, Crawford H, Payne R, Rousseau C, Rolland M, Honeyborne I et al.(2008). Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J VIROL vol. 82, (17) 8548-8559.
Prendergast A, Mphatswe W, Tudor-Williams G, Rakgotho M, Pillay V, Thobakgale C, McCarthy N, Morris L et al.(2008). Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. AIDS vol. 22, (11) 1333-1343.
Rousseau CM, Daniels MG, Carlson JM, Kadie C, Crawford H, Prendergast A, Matthews P, Payne R et al.(2008). HLA class I-driven evolution of human immunodeficiency virus type 1 subtype C proteome: Immune escape and viral load. J VIROL vol. 82, (13) 6434-6446.
Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, Carlson JM, Derdeyn CA, Tang JM et al.(2008). Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J EXP MED vol. 205, (5) 1009-1017.
Ramduth D, Thobakgale CF, Mkhwanazi NP, De Pierres C, Reddy S, van der Stok M, Mncube Z, Mphatswe W et al.(2008). Detection of HIV type 1 gag-specific CD4(+) T cell responses in acutely infected infants. AIDS RES HUM RETROV vol. 24, (2) 265-270.
Thobakgale CF, Ramduth D, Reddy S, Mkhwanazi N, de Pierres C, Moodley E, Mphatswe W, Blanckenberg N et al.(2007). Human immunodeficiency virus-specific CD8(+) T-Cell activity is detectable from birth in the majority of in utero-infected infants. J VIROL vol. 81, (23) 12775-12784.
Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Goulder P(2007). International perspectives, progress, and future challenges of paediatric HIV infection. Lancet vol. 370, (9581) 68-80.
Mphatswe W, Blanckenberg N, Tudor-Williams G, Prendergast A, Thobakgale C, Mkhwanazia N, McCarthy N, Walker BD et al.(2007). High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. AIDS vol. 21, (10) 1253-1261.
Frater AJ, Brown H, Oxenius A, Günthard HF, Hirschel B, Robinson N, Leslie AJ, Payne R et al.(2007). Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol vol. 81, (12) 6742-6751.
Honeyborne I, Prendergast A, Pereyra F, Leslie A, Crawford H, Payne R, Reddy S, Bishop K et al.(2007). Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J Virol vol. 81, (7) 3667-3672.
Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, Reddy S, de Pierres C et al.(2007). CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load. NAT MED vol. 13, (1) 46-53.
Return to top